Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 2826 to 2850

PHARMORUBICIN epirubicin hydrochloride 20mg/10mL injection vial Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
PHARMORUBICIN epirubicin hydrochloride 50mg/25mL injection vial Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
SOMAC pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
SOMAC pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
Ultra Nature Weight Loss + Cholesterol & Sugar Control Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Selima Pharmaceuticals
VIPDOMET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VIPDOMET 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VIPDOMET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VIPIDIA alogliptin (as benzoate) 12.5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VIPIDIA alogliptin (as benzoate) 25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VIPIDIA alogliptin (as benzoate) 6.25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle Cancelled under Section 30(1)(c) of the Act

15 August 2024

Cancellation by sponsor

Requested by Bayer Australia Ltd
Renopace Multivitamin & Minerals Enhanced with Omega-3 Cancelled at the request of the sponsor

5 August 2024

Cancellation by sponsor

Requested by Cancelled under Section 30(1)(c) of the Act
Trainade Hydration (Blueberry Flavour) Cancelled under Section 30(1)(c) of the Act

23 July 2024

Cancellation by sponsor

Requested by SB Functional Health Group Pty Ltd
Trainade Hydration (Blueberry Flavour) Cancelled under Section 30(1)(c) of the Act

23 July 2024

Cancellation by sponsor

Requested by SB Functional Health Group Pty Ltd
ASPEN METHADONE INJECTION methadone hydrochloride 10mg/1mL injection vial Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
ASPEN METHADONE INJECTION methadone hydrochloride 10mg/1mL injection vial Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
Barefoot Labs Whip Screen Bubblegum SPF50 Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Barefoot Labs Pty Ltd
Barefoot Labs Whip Screen Bubblegum SPF50 Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Barefoot Labs Pty Ltd
Barefoot Labs Whip Screen Watermelon SPF50 Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Barefoot Labs Pty Ltd
Barefoot Labs Whip Screen Watermelon SPF50 Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Barefoot Labs Pty Ltd
Biogency Grape Seed Capsules Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Biogency Pty Ltd
Biogency Grape Seed Capsules Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Biogency Pty Ltd
Biogency Synext Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Biogency Pty Ltd
Biogency Synext Cancelled under Section 30(1)(c) of the Act

18 July 2024

Cancellation by sponsor

Requested by Biogency Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

PHARMORUBICIN epirubicin hydrochloride 20mg/10mL injection vial Cancelled under Section 30(1)(c) of the Act

PHARMORUBICIN epirubicin hydrochloride 50mg/25mL injection vial Cancelled under Section 30(1)(c) of the Act

SOMAC pantoprazole 20mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

SOMAC pantoprazole 40mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

Ultra Nature Weight Loss + Cholesterol & Sugar Control Cancelled under Section 30(1)(c) of the Act

VIPDOMET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

VIPDOMET 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

VIPDOMET 12.5/850; 12.5 mg alogliptin (as benzoate) / 850 mg metformin hydrochloride film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

VIPIDIA alogliptin (as benzoate) 12.5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

VIPIDIA alogliptin (as benzoate) 25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

VIPIDIA alogliptin (as benzoate) 6.25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle Cancelled under Section 30(1)(c) of the Act

Renopace Multivitamin & Minerals Enhanced with Omega-3 Cancelled at the request of the sponsor

Trainade Hydration (Blueberry Flavour) Cancelled under Section 30(1)(c) of the Act

Trainade Hydration (Blueberry Flavour) Cancelled under Section 30(1)(c) of the Act

ASPEN METHADONE INJECTION methadone hydrochloride 10mg/1mL injection vial Cancelled under Section 30(1)(c) of the Act

ASPEN METHADONE INJECTION methadone hydrochloride 10mg/1mL injection vial Cancelled under Section 30(1)(c) of the Act

Barefoot Labs Whip Screen Bubblegum SPF50 Cancelled under Section 30(1)(c) of the Act

Barefoot Labs Whip Screen Bubblegum SPF50 Cancelled under Section 30(1)(c) of the Act

Barefoot Labs Whip Screen Watermelon SPF50 Cancelled under Section 30(1)(c) of the Act

Barefoot Labs Whip Screen Watermelon SPF50 Cancelled under Section 30(1)(c) of the Act

Biogency Grape Seed Capsules Cancelled under Section 30(1)(c) of the Act

Biogency Grape Seed Capsules Cancelled under Section 30(1)(c) of the Act

Biogency Synext Cancelled under Section 30(1)(c) of the Act

Biogency Synext Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?